Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
28,859,272
-
Shares change
-
-795,388
-
Total reported value, excl. options
-
$25,682,712
-
Value change
-
-$778,265
-
Number of buys
-
8
-
Number of sells
-
-17
-
Price
-
$0.8900
Significant Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q3 2016
49 filings reported holding AVEO - AVEO PHARMACEUTICALS INC - COM as of Q3 2016.
AVEO PHARMACEUTICALS INC - COM (AVEO) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,859,272 shares
.
Largest 10 shareholders include NEA Management Company, LLC (10,362,694 shares), PERCEPTIVE ADVISORS LLC (3,108,808 shares), RENAISSANCE TECHNOLOGIES LLC (2,595,400 shares), New Leaf Venture Partners, L.L.C. (2,590,673 shares), VANGUARD GROUP INC (2,420,586 shares), Sarissa Capital Management LP (2,000,000 shares), BlackRock Institutional Trust Company, N.A. (1,945,975 shares), Cormorant Asset Management, LLC (1,087,715 shares), Deer VI & Co. LLC (675,242 shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (514,051 shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.